Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Chronic Postsurgical Pain in Lung Cancer
NCT04585620Phase 2Unknown
- Start
- Sep 2022
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-thoracotomy pain syndrome (PTPS) comparing BTX-A with Placebo (2 arms). Primary endpoints: Rate of recruitment at 12 months and Incidence of treatment procedure disruption at 12 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
post-thoracotomy pain syndrome (PTPS)
Beyond the preview
Go deeper on NCT04585620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585620.